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Abstract
Muscle homeostasis involves de novo myogenesis, as observed in conditions of acute or chronic muscle damage. Tumor
Necrosis Factor (TNF) triggers skeletal muscle wasting in several pathological conditions and inhibits muscle regeneration.
We show that intramuscular treatment with the myogenic factor Arg
8-vasopressin (AVP) enhanced skeletal muscle
regeneration and rescued the inhibitory effects of TNF on muscle regeneration. The functional analysis of regenerating
muscle performance following TNF or AVP treatments revealed that these factors exerted opposite effects on muscle
function. Principal component analysis showed that TNF and AVP mainly affect muscle tetanic force and fatigue.
Importantly, AVP counteracted the effects of TNF on muscle function when delivered in combination with the latter. Muscle
regeneration is, at least in part, regulated by caspase activation, and AVP abrogated TNF-dependent caspase activation. The
contrasting effects of AVP and TNF in vivo are recapitulated in myogenic cell cultures, which express both PW1, a caspase
activator, and Hsp70, a caspase inhibitor. We identified PW1 as a potential Hsp70 partner by screening for proteins
interacting with PW1. Hsp70 and PW1 co-immunoprecipitated and co-localized in muscle cells. In vivo Hsp70 protein level
was upregulated by AVP, and Hsp70 overexpression counteracted the TNF block of muscle regeneration. Our results show
that AVP counteracts the effects of TNF through cross-talk at the Hsp70 level. Therefore, muscle regeneration, both in the
absence and in the presence of cytokines may be enhanced by increasing Hsp70 expression.
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Introduction
The maintenance of regenerative capacity through recruitment
or activation of resident stem cells is important for skeletal muscle
recovery following injury or disuse [1–3]. Loss of regenerative
potential is associated with numerous pathological conditions,
including dystrophy and cachexia [4]. Cytokines play an
important role both in eliciting muscle wasting and in blocking
muscle regeneration [5,6]. In particular, tumor necrosis factor-a
(henceforth referred to as TNF, in agreement with Clark [7]) is a
principal cytokine involved in the pathogenesis of muscular
dystrophy and other disease states such as cachexia [8–10].
Prolonged exposure to TNF is known to block myogenic cell
differentiation and muscle regeneration [6,11]. This occurs, at
least in part, through non-apoptotic caspase activation in
myogenic cells in vitro, which is also observed in interstitial stem
cells in the regenerating muscle following focal injury [6]. Caspase
inhibitors rescue muscle differentiation in vitro as well as muscle
regeneration in the presence of TNF, thereby showing that caspase
activity is required to mediate the effects of TNF. PW1 is an
effector of p53 cell death pathways and mediates Bax translocation
to the mitochondria [12]. PW1 and p53 are also jointly involved in
mediating cachexia [13]. PW1 is expressed in skeletal muscle
throughout development, in cultures of both myogenic cell lines
and primary cells as well as in the regenerating muscle [6,11,14].
PW1 is responsible for the recruitment of caspase-dependent
pathways that inhibit muscle differentiation in vitro as well as
muscle regeneration [6,11,12,15].
A key regulatory event of the caspase cascade is the association
of cytochrome c and apoptotic-protease-activating factor 1 (Apaf-
1). Following Bax translocation to the mitochondrial membrane,
Apaf-1 is released into the cytosol and initiates the caspase
cascade, with the activation of the constitutively expressed
procaspase-9 [16]. It has been demonstrated that the inducible
heat shock protein Hsp70 regulates caspase activation by directly
interacting with Apaf-1, and thereby deters procaspase-9 binding
to Apaf-1 for its activation [17]. Hsp70 has been reported to
protect skeletal muscle against cryolesion and age-related dys-
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overexpression prevents muscle atrophy [20], thereby extending
the beneficial effects of Hsp70 on muscle to the inhibition of
protein catabolism through the repression of the transcriptional
activities of NF-kB and Foxo3a [20], two factors that induce
muscle wasting [21,22].
Our group has shown that the neurohypophyseal nonapeptide
Arg
8-Vasopressin (AVP) positively regulates myogenic differenti-
ation [23,24]. In myogenic cells, AVP activates both the
calcineurin and CaMK pathways [25–27]. Furthermore, AVP
removes inhibitory signals, such as elevated cAMP levels, in the
early phases of differentiation [28]. We also showed that AVP
evoked PLD-mediated cytoskeleton remodeling, which enhances
cell-cell fusion during muscle differentiation [29]. AVP, which is
physiologically present in the plasma, induces differentiation in
serum-free myogenic cell cultures and positively interacts with
IGFs to promote muscle cell differentiation through upregulation
of Myf5 and myogenin [23]. A physiological role for AVP in
skeletal muscle is suggested by the expression of the AVP receptor
(V1aR) in human skeletal muscle [30,31] and of the oxytocin
receptor (also a AVP target) in cultured human myoblasts [32].
We have observed upregulation of V1aR expression upon muscle
regeneration (manuscript in preparation). An increase in circulat-
ing AVP levels during muscular activity has been reported for
different animal species, including man [33–35]. However, the
effects of AVP on skeletal muscle in vivo have yet to be fully
characterized.
Currently, the only known way to counteract the effects of TNF
on skeletal muscle in vivo is by competing with TNF using
immunological approaches [36]. Nonetheless, we have reported
that in vitro exposure to a static magnetic field counteracts TNF
inhibition of muscle differentiation [37], which suggests that it is
possible to override the negative effects of TNF on myogenesis.
Here we report for the first time that AVP rescues TNF inhibition
of muscle differentiation/regeneration in vitro and in vivo. The in
vivo application of our findings is of particular relevance since AVP
treatment significantly enhances the performance of regenerating
muscles. Muscle cells express both PW1 and Hsp70, and we show
that these two factors interact. We also show that TNF activates
caspases in vivo by downregulating Hsp70 without affecting PW1
expression. By contrast, AVP increases Hsp70 expression in
muscle. Hsp70 overexpression inhibits caspase activation and
rescues muscle regeneration in the presence of TNF. Taken
together, our results highlight the existence of cross-talk between
TNF and AVP-dependent pathways at the Hsp70 level that may
be exploited for gene or pharmacological approaches aimed at
enhancing muscle regeneration.
Results
AVP counteracts TNF-mediated inhibition of myogenic
differentiation in vitro
In order to test the ability of AVP to counteract TNF-mediated
inhibition of muscle differentiation, we induced differentiation of
the myogenic cell line L6 in the absence or in the presence of
TNF, AVP, or TNF and AVP combined. When cultured in the
presence of low serum levels L6 cells displayed the ability to form
multinucleated, myosin positive myotubes. Figure 1 shows that
TNF and AVP had opposite effects on this phenomenon, as can be
seen from both the fusion index and WB analysis for myosin heavy
chain content. However, AVP combined with TNF rescued
myogenic differentiation to levels similar to those of the control
(Fig. 1A, B and C).
Hsp70 binds to PW1 without affecting its expression
PW1 is a pivotal mediator of the pleiotropic effects of TNF and
mediates several pathways, including caspase and NF-kB activation
[11,38,39]. In an attempt to find novel PW1 partners, PW1 was
immunoprecipitated from several cell lines, and PW1 immunopre-
cipitation products were subjected to two-dimensional electropho-
retic analysisand liquid chromatographycoupledwithtandemmass
spectrometry (LC-MS/MS). This approach highlighted several
potential interactions, including the binding of PW1 to Hsp70
(Supplemental Fig. S1). Indeed, LC-MS/MS revealed that the
majority of the spots in 2D-gels consisted of Hsp70 peptides
corresponding to fragments of Hsp70 previously isolated as co-
immunoprecipitation product. These evidence occurred in muscle
cells, which endogenously express PW1, and in non-muscle cells,
where PW1 expression was ectopically driven. This pointed out
Hsp70 as a potential candidate to form complexes with PW1 and
prompted us to further investigate PW1 and Hsp70 expression and
interaction.
While PW1 expression is widespread in both myogenic cell lines
and primary cell cultures as well as in muscle stem cells in vivo, its
expression in the myogenic cell line L6 has not been reported to
date. We observed that PW1 is expressed in the vast majority of L6
cells both in growth medium and upon differentiation (Fig. 2A).
We noted that PW1 has a double nuclear and cytoplasmic
localization in both single cells and myotubes. We also
demonstrated that Hsp70 is constitutively expressed in L6 cells
and its expression is upregulated by heat shock (Fig. 2B). PW1 is
coexpressed with Hsp70 in myogenic cells both in the basal
condition and upon heat shock treatment (Fig. 2B), which supports
previous data pointing to a possible interaction. To verify whether
increased Hsp70 expression affects PW1 expression or localization,
we overexpressed Hsp70 in L6 cells and found that this has no
effect either on the percentage of cells expressing PW1 or on its
localization (Fig. 2C).
Co-immunoprecipitation experiments of endogenous PW1 and
Hsp70 were performed and confirmed that L6 cells express both
factors. In particular, we showed the presence of PW1-Hsp70
complexesbyimmunoprecipitatingcellextracts with an anti-PW1 Ab
and blotting with an anti-Hsp70 Ab, or by inverting this procedure
(Fig. 3A). To further demonstrate the interaction between Hsp70 and
PW1, the latter was ectopically expressed in 293 cells by transient
transfection; cotransfection with an expression vector for ß-
galactosidase was used to monitor transfection efficiency (data not
shown). To overexpress PW1, two different constructs were used: one
contained the HA region as a tag followed by the sequence
corresponding to its exon 9, while the other contained the full length
form of PW1. WB analysis of cell extracts revealed robust PW1
expression following expression of both constructs (Fig. 3B). Under
these conditions, both an anti-HA Ab and an anti-HSP70 Ab
immunoprecipitated PW1 (Fig. 3B). Immunoprecipitation was
specific, as demonstrated by the fact that no PW1 was recovered
when an empty vector was expressed in the cells. In addition, we
found Hsp70 in a complex immunoprecipitated with an anti-HA Ab
as well as with an anti-PW1 Ab incells overexpressing PW1(Fig. 3C).
These findings indicate Hsp70-PW1 interaction.
Hsp70 reduces TNF-dependent caspase activity
TNF induced caspase activation in L6 cells. Given the well-
established Hsp70 inhibitory effects on caspase cascade activation,
we tested whether Hsp70 affected TNF-dependent caspase
activation in L6 cells. We overexpressed Hsp70 in these cells
and verified the increased levels of this protein by WB analysis
(Fig. 4A) and, on a single cells basis, by cotransfection with an
expression vector for green fluorescence protein (SNAP-GFP)
Caspase in Muscle Regeneration
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5570(Fig. 4B). The latter allowed us to follow the effects of Hsp70
overexpression on TNF-induced caspase activity, highlighted by
means of a red-fluorescence caspase substratum (Fig. 4B). Most
(86%) of the mock transfected, TNF-treated L6 cells displayed
caspase activation, whereas only 50% of the Hsp70 expressing cells
displayed caspase activation in the presence of TNF (Fig. 4C). As
controls for the caspase assay, we used puromycin-treated cells
incubated, respectively, with or without the red-fluorescence
caspase substratum (Fig. 4B, small, upper panels).
AVP counteracts the negative effects of TNF on muscle
regeneration
We have reported that TNF injection into regenerating muscle
hampers muscle regeneration following focal injury [6]. We
demonstrated the ability of AVP to override the negative effects of
TNF on myogenic differentiation in vitro. We therefore extended our
analysis to injured muscles, treated with a combination of AVP and
TNF, in order to evaluate the ability of AVP to rescue regeneration
in the presence of TNF. We analyzed the effects of these treatments
on the initial regenerative response, by WB evaluation of satellite
cell activation markers, namely Pax7 and desmin. We found that at
day 4.5 of regeneration AVP greatly increased the levels of both
Pax7 and desmin, as compared to the control, while TNF did not
affect the levels of these proteins (Fig. 5A); the combination of AVP
and TNF determined lower levels of Pax7 but not of desmin, as
compared to the control, and lower levels of both markers if
compared to AVP treatment (Fig. 5A). The expression kinetics of
neonatal myosin heavy chain (neoMHC), a marker expressed by
nascent regenerating fiber, showed, when compared with the
control,thatAVPextendstheexpressionofthismarker,TNFdelays
neoMHC expression, while the combination of AVP and TNF
yields a peak of neoMHC no later that 4.5 days following injury, i.e.
overlapping that of the control (Fig. 5B).
To assess regeneration at the morphological level, we analyzed
the fibers with centrally located nuclei. For this purpose, we
counted the number of regenerating fibers per cross-section and
we measured the regenerating fiber cross-sectional area (Fig. 5C
and D). One-way Anova analysis showed that intramuscular
treatments effected the number of regenerating fibers by a quasi-
significant level after one week of regeneration (df:3,19; F=3.137,
p=0.05). Anova then showed that treatments significantly
increased the number of regenerating fibers after two weeks of
regeneration (df:3,17; F=4.657, p=0.02), thus suggesting that
treatments required time to fully exert their effects on muscle
regeneration. As shown in Figures 5C and D, TNF and AVP
exerted opposite effects on muscle regeneration, these effects
becoming particularly evident after two weeks of regeneration. At
this time point, AVP treatment determined a significant increase
in the number and size of regenerating fibers if compared with
both control and TNF-treated muscles. In addition, AVP fully
Figure 1. TNF and AVP differentially regulate myogenic
differentiation in vitro.A ) The L6 cell line was induced to
differentiate in the continuous presence of PBS (CTR), AVP, TNF, or
TNF and AVP combined (TNF+AVP). Myosin (red) was immunostained to
assess cell differentiation. Nuclei were detected with DAPI (blue). Scale
bar=100 micron. B) Quantitative analysis of myogenic differentiation
(% FUSION) of L6 cells. **=p,0.04 vs TNF; *=p,0.05 vs CTR, by
Student’s t test. Data are the means6SEM of values from three
independent experiments performed in triplicate. C) Myosin (MHC) and
a-tubulin levels detected by western blot in cells treated as described
above. TNF blocks whereas AVP promotes myogenic differentiation. In
the presence of TNF, AVP rescues myogenic differentiation to the level
of the control. Data are representative of three independent
experiments.
doi:10.1371/journal.pone.0005570.g001
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PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5570Figure 2. Hsp70 and PW1 are coexpressed and colocalize in L6 cells. A) Immunofluorescence analysis of PW1 expression in L6 cells in growth
medium (GM) and following 5 d of differentiation (DM). PW1 (green) displays nuclear and cytoplasmic localizations in both conditions. DAPI-stained
nuclei are blue. Panels on the left represent a negative control incubated without primary Ab (No I Ab). Embedded in the panels is the mean percentage
of PW1-expressing cells6SEM, resulting from three independent experiments performed in triplicate. Scale bar=100 micron. B) Immunofluorescence
analysisofHsp70(red)andPW1 (green)expressioninL6cellsculturedinGMsubjectedornot subjectedtoheatshocktreatment(HS),asdescribedinthe
Materials and Methods. Nuclei were visualized by DAPI staining (blue). The lowest panels represent merged images. The panels on the left represent a
negative control incubated without primary Ab (No I Ab). PW1 and Hsp70 are expressed in the same cells, both in basal conditions and following heat
shock treatment, which upregulates Hsp70 expression. PW1 and Hsp70 colocalize in both the cell nucleus and cytoplasm. Data are representative of six
independent experiments. Scale bar=100 micron. C) Immunofluorescence analysis of PW1 expression in L6 cells overexpressing Hsp70. PW1 staining
(green) was performed on cells transfected with an expression vector for Hsp70. Transfected cells were identified by coexpression of red fluorescent
protein (RFP, red). Nuclei are counterstained with DAPI (blue) and tricolour, merged images are shown. All the possible combinations were observed,
with cells expressing or not expressing PW1 in the presence of RFP and Hsp70 expression. The percentage of PW1 positive cells among the cells
transfectedwitheitherpCDNAandRFPorHsp70andRFPwasevaluatedin10randomlychosenfieldsforeachsample.Shownisthemean6SEMofthree
replicate experiments. Hsp70 and PW1 are both expressed in muscle cells and Hsp70 expression levels do not affect PW1 expression.
doi:10.1371/journal.pone.0005570.g002
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PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5570Figure 3. Hsp70 and PW1 physically associate. A) Co-immunoprecipitation of PW1 and Hsp70 in myogenic cells. Equal amounts of L6 whole
cell extracts (E) were subjected to immunoprecipitation (IP) of endogenous PW1 or endogenous Hsp70 proteins using an anti-PW1 antibody or an
anti-Hsp70 antibody, respectively. The presence of PW1 and Hsp70 was assessed by Western blot on whole cell extracts and on the
immunoprecipitated products. B) Co-immunoprecipitation of Hsp70 and ectopically expressed PW1. HEK293 cells were transiently co-transfected
with an expression vector containing the HA-tagged exon 9 region of PW1 (HA-PW1 EX9), a full-length PW1 construct (PW1 FL) or the empty vector
(pcDNA), by the calcium phosphate method. 48 h after transfection, equal amounts of whole cell extract (500 mg) were subjected to
immunoprecipitation of PW1 or Hsp70 as indicated, by using a mouse monoclonal antibody against HA tag or against Hsp70, or a polyclonal
antibody against PW1 (IP). The pellets of the immunoprecipitation or an aliquot of the whole extract were analyzed by Western blot using an anti-
PW1 antibody. In C the reciprocal experiment is shown, where HEK293 cells were transiently co-transfected with an expression vector for HA-tagged
PW1 (HA-PW1 EX9), or a full-length PW1 construct (PW1 FL). Cell extracts were subjected to immunoprecipitation of PW1 or Hsp70 as indicated, by
Caspase in Muscle Regeneration
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ating fibers, following which fiber size distribution mirrored that
obtained upon treatment with AVP alone (Fig. 5D).
Overall, these data suggest that AVP and TNF affect muscle
regeneration in different ways, and that it may be possible to
exploit AVP to enhance myogenesis in vivo and counteract the
negative effects of TNF on regeneration.
Muscle performance mirrors the extent of muscle
regeneration
We performed a functional analysis of regenerating muscles
treated as described above to evaluate whether differential
regeneration altered muscle performance. An isometric experi-
mental protocol was applied to characterize the mechanical
properties of uninjured and of regenerating muscles treated with
TNF, AVP, or TNF and AVP combined. An explorative analysis
performed by Student’s t test on the functional properties of
muscle pointed to the existence of a significant difference between
the mean tetanic force and the mean specific force of TNF-treated
muscles, compared with the control regenerating muscle, after 1
week of regeneration (Table 1 and Fig. 6A), suggesting that TNF
hampered muscle functional recovery after injury (Table 1). By
contrast, AVP treatment rescued muscle performance in the
presence of TNF (Table 1 and Fig. 6A). No significant differences
between treatments were observed in the fatigue time of
regenerating muscle one week after injury (Table 1).
Since the morphological effects exerted by TNF and AVP on
muscle regeneration peaked two weeks after injury, we extended
the muscle functional analysis to this time point of regeneration.
We noted that the average specific force of regenerating, control
muscle was 87610.3 mN and 9064.9 mN at one and two weeks
following injury, respectively. The two values are not significantly
different. As Multiple Anova (Manova) analysis showed that the
treatments described above affected muscle performance
(P,0.0005 by Hotelling’s Trace test), we decided to further
investigate which muscle functional parameters were significantly
affected in the different conditions. One-way Anova analysis,
Figure 4. Hsp70 overexpression reduces TNF-mediated caspase activation. A) L6 cells were transfected with SNAP-GFP and an excess of
Hsp70 expression vector or empty vector. Overexpression of Hsp70 was assessed by Western Blot analysis of cell lysates normalized for tubulin
expression. The cells, transfected as indicated, were treated for 16 h with TNF, and floating and adherent cells (detached by trypsin) were pooled. B)
Caspase activity (red) was detected with CaspGLOW while transfected cells were detected by the expression of SNAP-GFP (green). Puromycin-treated,
apoptotic cells incubated or not incubated with CaspGLOW were used as a positive (Pos ctrl) and negative (Neg ctrl) control for the caspase assay,
respectively. From left to right, the panels show phase contrast, green channel, red channel and merged images (the latter with increased contrast to
highlight both signals). Only the apoptotic cell (arrowhead), characterized by a condensed nucleus, shows a bright fluorescence due to intense
caspase activation. TNF-treated cells display a weaker fluorescence than apoptotic cells. C) The percentage of mock transfected cells that displayed
caspase activity was evaluated by counting 10 randomly chosen fields in triplicate experiments. Shown is the mean6SEM of values from three
independent experiments. Hsp70 overexpression reduces the percentage of cells displaying active caspases in the presence of TNF.
doi:10.1371/journal.pone.0005570.g004
using a mouse monoclonal antibody against HA tag or against Hsp70, or a polyclonal antibody against PW1 (IP). The pellets of the
immunoprecipitation or an aliquot of the whole extract were analyzed by Western blot using an anti-Hsp70 antibody. A physical interaction between
PW1 and Hsp70 is demonstrated both for the endogenous proteins in muscle cells and when PW1 is ectopically expressed in non-muscle cells. Data
are representative of at least three independent experiments.
doi:10.1371/journal.pone.0005570.g003
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PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5570Figure 5. AVP counteracts TNF inhibition of muscle regeneration. A) WB analysis on extracts from adult (UNINJURED) and regenerating
Tibialis anterior injected with PBS (C), AVP (A), , TNF (T) or TNF and AVP combined (T+A) and analyzed at 4.5 days following injury. The levels of Pax7
and desmin proteins were used as markers of satellite cell activation, while the levels of tubulin were the loading control. AVP increases satellite cell
Caspase in Muscle Regeneration
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differences in tetanic and specific force as well as in fatigue time
between the treated muscles (with treatments being: PBS, TNF,
AVP and TNF+AVP; df:5; F:4.486; p=0.002 for tetanic force;
df:5; F:4.489; p=0.002 for specific force; df:5; F:3.006; p=0.018
for fatigue time; total df:63). As summarized in Table 2, we
statistically investigated which muscle functional properties were
affected most. This post hoc analysis showed that the specific and
tetanic force of adult, uninjured muscles was significantly different
from that of regenerating muscle (p,0.05 by LSD test), with the
exception of the AVP-treated muscles. In particular, 24 hours
after injury, the tetanic and specific muscle tetanic force was
significantly lower (by more than 50%) than that of adult
uninjured muscles (p,0.005 at LSD test); this deficit was partially
recovered in control conditions and, though to a lesser extent,
upon TNF treatment, which reduced both tetanic and specific
force by about 10% if compared with controls; AVP-treated
muscle exhibited a significant increase in tetanic and specific force
(approx. 34%) if compared with regenerating control muscle
(p,0.05 by LSD test); AVP combined with TNF yielded a muscle
tetanic force comparable to that of TNF-treated muscle (Table 2).
However, the force deficit observed in TNF-treated muscle was
accompanied by a more rapid onset of fatigue (p,0.05 at LSD
test), which was reversed by AVP treatment (Table 2). Thus, TNF
worsened the performance of regenerating muscle, AVP enhanced
performance, whereas combined TNF and AVP treatment yielded
muscle functional output comparable to that of control muscles.
The beneficial effects of AVP counteracting the negative effects
of TNF were less evident after two weeks than after one week of
regeneration, probably owing to the partial functional recovery of
the injured muscles 2 weeks after injury regardless of the
treatment. In order to determine the similarities and differences
between the treatments more accurately, we performed a principal
components analysis (PCA) both on the afore-mentioned param-
eters and on additional parameters of muscle performance. PCA
highlighted the two parameters that account for most of the
variability between the AVP and TNF treatments: muscle force
and fatigue (Table 3). In particular, the 1
st principal component
closely correlated with tetanic force and specific force, while the
2nd principal component closely correlated with the fatigue index
and fatigue time (the variables correlated with the two principal
components can be identified by the highest score coefficients in
the absolute values shown in Table 3). To depict a large set of
data, a diagram of the centroids (indicating the mean values of
each treatment group) was plotted in a bidimensional space,
defined by the first and second principal components (Fig. 6B).
The position of a centroid in the graph thus reflects and
summarizes the behavior of a group of treated muscles. Indeed,
the two principal components varied markedly depending on the
different muscle treatments (Fig. 6B). In contrast to injured
muscles, the uninjured muscles yielded positive and negative
values respectively for the 1
st and 2
nd principal components (as
shown by their position relative to the two zero axes in Figure 6B).
The behavior that differed most from that of the freshly injured
muscle was that of the uninjured muscle (ctrl 24 h), which yielded
1
st and 2
nd principal component negative values. CTR and AVP-
treated muscle centroids yielded positive 1
st and 2
nd principal
component values, which are indicative of a progression toward
normal functional parameters (Fig. 6B). TNF-treated muscle
performance resembled that of control muscle 24 hours after
injury despite the fact that the TNF-treated muscles were afforded
a significant recovery time (two weeks after injury); this points to
the persistence of a functional deficit. It is noteworthy that AVP
treatment combined with TNF significantly enhanced muscle
function, as shown by the shift of the centroid toward the position
of the injured and uninjured controls (Fig. 6B).
Overall, the functional performance yielded by different
treatments correlated with the extent of muscle regeneration,
thereby highlighting the importance of prompt regeneration for
the full recovery of muscle functional efficiency.
AVP counteracts TNF-mediated caspase activation,
affecting Hsp70 but not PW1 expression
Given the pivotal role played by caspases in TNF-dependent
inhibition of myogenesis in vitro and in vivo, we investigated the
effects of AVP on caspase activity, both in the absence and
presence of TNF. By means of fluorimetric assay on regenerating
muscle extracts, we showed that AVP did not, unlike TNF which
mediated a significant increase in caspase activity, modulate
caspase activity (Fig. 7A). Worthy of note is the fact that AVP
activation, while TNF does not affect this phenomenon and, in combination with AVP, allows satellite cell activation similar to the control. Data are
representative of at least three independent experiments.B) RT-PCR from adult (UNINJURED) and regenerating Tibialis anterior injected with PBS
(CTRL), TNF (TNF), AVP (AVP), or TNF and AVP combined (TA) and analyzed at 4.5, 7 and 10 days following injury. Neonatal myosin heavy chain
expression was monitored, normalized by the GADPH expression. No RNA was reverse-transcripted in the negative control (neg). Data are
representative of three independent experiments C) Injured Tibialis anterior injected with PBS (CTR), TNF, AVP, or TNF and AVP combined (TNF+AVP)2
and 4 days following injury, and analyzed 1 or 2 weeks after injury. Representative H&E-stained muscle cross cryosections showing regenerating
fibers, after 2 weeks of regeneration, characterized by the presence of centrally located nuclei, 2 weeks after injury. Insets, higher magnification. Scale
bar=100 micron. D) Histograms showing the distribution of the regenerating fiber cross sectional areas (FIBER NUMBER/CROSS SECTION) in different
size classes (CROSS-SECTIONAL AREA), 1 week (left column) and 2 weeks (right column) after injury. The median value is shown as a red bar. The total
number of regenerating fibers for muscle cross section (REGEN. FIBER NUMBER) is shown on top of each panel. Data are the means6SEM of values
from at least three independent experiments performed in triplicate (9,n,14 for each experimental condition). ANOVA showed a highly significant
effect of treatments on muscle regeneration 2 weeks after injury. LSD was used as a post hoc test. #=p,0.05 vs CTR; *=p,0.05 vs CTR or vs TNF;
**=p,0.05 vs TNF. The following phenomena are apparent at 2 weeks of regeneration: AVP enhances whereas TNF reduces muscle regeneration;
AVP treatment counteracts the negative effects of TNF.
doi:10.1371/journal.pone.0005570.g005
Table 1. Functional analysis of skeletal muscle after one week
of regeneration.
Parameters Treatments
CTR TNF AVP TNF+AVP
Force (% of CTR) 100.063.3 59.1612.9* 88.6622.3 93.1620.0
Specific Force
(% of CTR)
100.0611.1 50.767.6* 96.1621.2 90.5625.9
Fatigue time (sec) 18.861.14 19.060.4 18.861.3 18.460.7
Injured Tibialis anterior muscles were injected with PBS (CTR), TNF, AVP or TNF
and AVP combined (TNF+AVP) 2 and 4 days after freeze injury, and analyzed
after one week of regeneration. Data obtained from 6,n,7, for each
experimental condition, are shown as mean6SEM.
*p,0.05 vs. CTR by Student’s t test.
doi:10.1371/journal.pone.0005570.t001
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Parameters Treatments
UNINJURED CTR 24 h CTR TNF AVP TNF+AVP
Force (% of CTR) 143.9635.2
* 68.5611.2
u 100.069.0 92.2615.0 134.067.3
# 87.666.7
Specific Force (% of CTR) 129.1637.0
* 53.2616.5
u 100.068.9 87.1614.9 134.268.5
# 87.2626.2
Fatigue time (sec) 15.6360.01 15.860.2 21.762.0 17.062.0
# 20.662.3 20.161.0
Injured Tibialis anterior muscles were injected with PBS (CTR), TNF, AVP or TNF and AVP combined (TNF+AVP) 2 and 4 days after freeze injury and analyzed two weeks
following injury. Regenerating muscles were compared with uninjured muscles and freshly (24 h following damage) injured muscles. Data obtained from8 ,n,17, for
each experimental condition, are shown as mean6SEM.
*p,0.05 vs. CTR, TNF or TNF+AVP and p,0.005 vs. CTR 24 h by LSD test.
up,0.005 vs. UNINJURED and p,0.05 vs. either CTR or AVP by LSD TEST.
#p,0.03 vs. CTR by LSD test.
doi:10.1371/journal.pone.0005570.t002
Figure 6. AVP counteracts TNF inhibition of muscle function. A) AVP and TNF differentially affect muscle performance. The Tibialis anterior
muscle was subjected to freeze injury, injected with PBS (CTR), AVP, TNF, or TNF and AVP combined (TNF+AVP) 2 and 4 days later, and analyzed 1
week following injury. One week after injury, the TNF-treated muscle generates a tetanic force that is significantly lower than that achieved with all
other treatments. Data obtained from 6,n,7, for each experimental condition, are shown as mean6SEM; * p,0.05 vs. CTR by Student’s t test. B)
Principal Components Analysis (PCA) was performed using the multiple parameters from the functional data sets obtained both 1 and 2 weeks
following injury, as described in the Materials and Methods. One example of a data set included in the PCA are the specific force recordings described
in A. The centroids represent the mean values obtained from single measurements on the muscles of each of the 6 treatment groups (uninjured;
CTRL 24 h; CTRL; AVP; TNF; AVP+TNF). The centroids were plotted in the bidimensional space defined by the 1
st and 2
nd principal component
functions shown in Table 3. The differences in behaviour between the injured muscles and uninjured muscles vary significantly depending on the
treatments: the TNF-treated muscle exhibits the greatest difference from uninjured muscle and is closest to freshly injured muscle (CTRL 24 h, i.e. a
time gap that is not sufficient for functional recovery to occur), which indicates that TNF hampers functional recovery of damaged muscle, whereas
AVP rescues this phenomenon.
doi:10.1371/journal.pone.0005570.g006
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combined with TNF (Fig. 7A).
Given the ability of Hsp70 to inhibit caspase activation (as
shown in Figure 4), we measured Hsp70 protein levels in these
conditions. We found that AVP and TNF modulate Hsp70 levels
positively and negatively, respectively (Fig. 7B). AVP was able to
override the effects of TNF on protein levels when the two factors
were combined (Fig. 7B).
Immunofluorescence analysis for PW1 and for laminin revealed
that PW1 expression is high both in the interstitial space and in the
muscle compartment of regenerating muscle, but is not signif-
icantly modulated by any treatment (Fig. 7C).
Hsp70 counteracts TNF-dependent inhibition of
regeneration
Since protein levels appeared to be inversely correlated to
caspase activity in response to TNF and/or AVP, we overex-
pressed Hsp70 by electroporation-mediated gene delivery in the
regenerating muscle to investigate its effects on regeneration. The
efficiency of Hsp70 overexpression in electroporated muscles was
shown by WB analysis and co-transfection with an expression
vector for SNAP-GFP (Fig. 8A and B). In this context, we observed
that Hsp70 is expressed at similar levels in adult and regenerating
muscle, which is in agreement with a previous report [40]. To
analyze the output of Hsp70 overexpression in regenerating
muscle treated with AVP and/or TNF, we measured the
regenerating fiber cross-sectional area after two weeks of
regeneration (Fig. 8B and C). Two-way Anova revealed that both
Hsp70 overexpression and the treatments significantly affected the
regenerating fiber area (F=4.77, p=0.0442 for hsp70 overex-
pression; F=14.93, p=0.0001 for treatments). Anova also showed
that Hsp70 overexpression in vivo interacted with treatments,
thereby affecting the regenerating fiber size (F=4.44, p=0.0188
for interaction Hsp70 x treatments). In particular, mock
electroporated muscle fiber size recapitulated the results obtained
in non-electroporated muscle: TNF significantly reduced the
regenerating fiber size if compared with the control (p,0.01 vs.
MOCK PBS, by Tukey HSD test), AVP significantly increased the
regenerating fiber size, if compared with the control (p,0.01 vs.
MOCK PBS, by Tukey HSD test), whereas AVP and TNF
combined rescued the TNF-mediated reduction in fiber size
(p,0.01 vs. MOCK TNF, by Tukey HSD test) (Fig. 8C). It is
noteworthy that TNF did not negatively affect fiber size in muscles
overexpressing Hsp70 (p,0.01 vs. MOCK TNF, by Tukey HSD
test) (Fig. 8C). Hsp70 overexpression had a slightly hypertrophic
effect on the regenerating fiber size, which was not further
increased by AVP treatment, either alone or in combination with
TNF (Fig. 8C). Taken together, these results demonstrate that
TNF-mediated inhibition of regeneration requires Hsp70 down-
regulation, and suggest that AVP counteracts the TNF-mediated
effects on muscle regeneration by maintaining high Hsp70 protein
levels.
Discussion
Inflammatory cytokines play an important role in triggering
skeletal muscle fiber growth and regeneration [41,42]. However,
chronic exposure to inflammatory cytokines is deleterious for
skeletal muscle homeostasis and function in a variety of
pathological conditions [4,36]. In particular, the negative effects
exerted by TNF on muscle include insulin resistance, downreg-
ulation of regenerative pathways and upregulation of protein
catabolism [4,5,43]. There are no effective means of blocking or
overriding the effects of TNF on muscle cells besides immunolog-
ical treatments aimed at TNF [36]. Several reports indicate that
insulin-like growth factor I (IGF-I) fails to prevent TNF-mediated
muscle atrophy and block of differentiation, one of the reasons
being a general downregulation of IGF-I dependent signaling
pathways exerted by TNF [44–47]. We tested whether intramus-
cular treatment with AVP, which is also a positive regulator of
muscle differentiation, counteracts the negative effects exerted by
TNF on muscle. AVP potently induces myogenesis in vitro
[23,24,26,27,48]. In vivo muscle specific AVP receptor (V1aR)
expression is positively modulated upon regeneration (manuscript
in preparation). Circulating AVP is increased by exercise, i.e.
during intense muscular activity [33–35]. This suggests that AVP
plays a role in skeletal muscle homeostasis and physiology during
postnatal life.
The explorative approach we used to test TNF-AVP cross-talk
in muscle cells, which consisted in treating L6 myogenic cells with
TNF, AVP, or TNF and AVP combined, showed that AVP
completely overrode the TNF blockade of differentiation. This
evidence encouraged us to treat regenerating muscle. In vivo we
found that TNF and AVP displayed opposite effects on
regeneration; indeed, TNF delayed and reduced this process,
whereas AVP significantly enhanced and extended the kinetics of
regenerating fiber formation. As a consequence, AVP had
paradoxical effects on regeneration hallmarks: first, neoMHC
expression was delayed three days as compared to controls, likely
due to prolonged satellite cell proliferation, which in fact gave rise
to nascent regenerating fibers for an extended period of time;
secondly, the abundance of regenerating fibers of all sizes,
including small, newly formed fibers, in the presence of AVP,
determined a median regenerating muscle fiber area not
significantly different from that of TNF-treated muscle. Regener-
ating muscle exposed to both TNF and AVP was similar to control
muscles, which indicates that it is possible to counteract the
negative effects of TNF not only on myogenic differentiation in
culture, but also on regeneration. It is well established that satellite
cell activation precedes their fusion into regenerating fibers and
that persistent Pax7 expression inhibits their progression through
myogenic differentiation [49,50]. In agreement with these reports,
our data suggest that: AVP per se delays the onset of the
differentiation phase of regeneration by enhancing satellite cell
activation, still predominant at day 4.5; TNF does not negatively
affect satellite cell activation, but it inhibits satellite cell fusion and
differentiation, as we and others reported [6,51]; the combination
of AVP+TNF rescues NeoMHC expression at day 4.5 (a
Table 3. Component score coefficient matrix used for
Principal Component Analysis.
Variables
1
st Principal
Component
2
nd Principal
Component
Tetanic force 0.444 20.243
Weight of each muscle 20.019 20.084
Specific force 0.450 20.216
Fatigue index 0.154 0.546
Fatigue time 0.249 0.478
Shown are the coefficients by which variables are multiplied to obtain the
principal components as described in the Materials and Methods. The variables
that correlate with the two principal components (highest score coefficient
absolute values) best are tetanic force and specific force for the 1st principal
component, and the fatigue index and fatigue time for the 2nd principal
component.
doi:10.1371/journal.pone.0005570.t003
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PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5570Figure 7. AVP counteracts TNF-mediated caspase activation and modulates Hsp70 but not PW1 expression. The Tibialis anterior was
injured and injected with PBS (CTR), TNF, AVP or TNF and AVP combined (TNF+AVP) 2 and 4 days later. A) Caspase activity was detected in muscle
lysates 4.5 days following injury by fluorimetric analysis, as described in the Materials and Methods. Caspase activity was normalized by DNA content
and expressed as a fold increase over PBS treated muscles (CTR). The results shown are the mean6SEM of five independent experiments performed in
triplicate. Student’s t test: *=p,0.03 vs CTR. TNF significantly increases caspase activity in regenerating muscles, an effect rescued by co-treatment
with AVP. B) Western blot analysis on regenerating Tibialis anterior, treated as described above, 1 week following injury and relative density plot of
Hsp70 bands normalized over tubulin band density. TNF reduces Hsp70 protein levels, whereas AVP increases Hsp70 protein levels in regenerating
muscles in the absence or presence of TNF. C) Regenerating Tibialis anterior cryosections stained for PW1 (green) and laminin (red) by indirect
immunofluorescence 4.5 days after injury. PW1 positive nuclei/mm
2 of the regenerating area vs treatment were evaluated and plotted. The results
shown are the mean6SEM of three independent experiments. Scale bar=100 micron. No statistically significant difference in the number of PW1
expressing cells was observed.
doi:10.1371/journal.pone.0005570.g007
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PLoS ONE | www.plosone.org 11 May 2009 | Volume 4 | Issue 5 | e5570Figure 8. Hsp70 overexpression rescues muscle regenerating fiber size in the presence of TNF. The Tibialis anterior was injured and
injected with PBS (CTR), TNF, AVP or TNF and AVP combined (TNF+AVP) 2 and 4 days later. A) Hsp70 expression by Western blot analysis in adult,
uninjured (ADULT) and regenerating (REGEN) Tibialis anterior 1 week following injury; also shown are Hsp70 expression levels in muscles
electroporated with an empty (MOCK) or an Hsp70 expression vector (HSP70) after 4.5 days of regeneration and analyzed after 1 week of
regeneration. Hsp70 is not upregulated during regeneration and is enhanced by electroporation-mediated gene delivery. B) The Tibialis anterior were
injured and injected with PBS (CTR), TNF, AVP or TNF and AVP combined (TNF+AVP) 2 and 4 days later. Gene delivery by electroporation of the
expression vector for Hsp70 (HSP70) or the matching empty vector (MOCK) was performed 4.5 days after injury. H&E staining of representative areas is
shown. The insets show SNAP-GFP expression (green) in adult and in regenerating fibers (arrows), which can be identified by the presence of centrally
located nuclei (blue). Scale bar=100 micron. C) Muscles were analyzed after two weeks of regeneration by measuring the cross-sectional area of the
regenerating fibers (REGENERATING FIBER SIZE). Data are the means6SEM of values from three independent experiments performed in duplicate. The
regenerating fiber size of TNF-treated, MOCK-electroporated samples was significantly different vs. all other conditions tested, such as: PBS-treated,
MOCK-electroporated; AVP-treated, MOCK-electroporated; TNF+AVP-treated, MOCK-electroporated; PBS-treated, Hsp70-electroporated; TNF-treated,
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inducing proper Pax7 downregulation and by favouring the
resolution of the inflammatory phase (data not shown). It is worth
noting that while inflammatory cytokines are essential for
recruitment of satellite cells to muscle fibers [41], pro-myogenic
factors, such as IGF-I [52], promote regeneration by accelerating
the modulation of inflammatory cytokine effects in regenerating
muscles. The full elucidation of the complex signaling pathways
triggered by TNF and AVP in muscle is under investigation.
However, the abolishment of the inhibitory effect exerted by TNF
on muscle regeneration after injury constitutes a tempting
approach for the therapy of diseases involving muscle fiber
damage [53,54].
Since most of the adverse effects on patients suffering from
muscle disease derive from impaired muscle performance, we were
particularly interested in the functional output of regenerating
muscle treated with TNF, AVP, or TNF and AVP combined. As
mentioned above, these treatments yielded varying degrees of
muscle regeneration. When considering physiological muscle
outputs, such as tetanic force and fatigue, TNF-treated muscles
took markedly longer to functionally recover following injury than
muscles subjected to all other treatments. Thus, TNF may affect
muscle performance by impairing regeneration. Impaired muscle
regeneration may be an additional mechanism in addition to fiber
atrophy and sarcomere dismantling [55] accounting for cytokine-
mediated decrease of muscle force. TNF treatment not only
negatively affected muscle tetanic force but also accelerated muscle
fatigue. A TNF-dependent decrease in muscle force and induction
of muscle weakness has previously been observed in ex vivo
experiments [56]. Interestingly, AVP rescued the effects of TNF by
increasing the number of regenerating fibers, thus enhancing the
tetanic force production and resistance of the regenerating
muscles. We found that differences in the fatigue time between
treatments inversely correlated with caspase activity, which is in
agreement with a previous paper that found an association
between increased caspase activation and weakness [57]. The two
injections we used in our experimental system did not modify the
muscle fiber size of the undamaged, i.e. non-regenerating, fibers
(data not shown). On the basis of these findings, we infer that the
differences in evoked muscle performance are associated with
variations in the degree of muscle regeneration, and not with
hypertrophy/atrophy phenomena in the remaining (undamaged)
portion of the muscle. The association between the extent of
muscle regeneration and its functional output indicates how
important prompt and efficient regeneration following injury is if
proper muscle function is to be maintained. Worth noting, the
control regenerating muscle does not fully recover within two
weeks following injury, at which time it still develops a force
significantly lower than uninjured muscles. Our observation is in
agreement with other reports, showing that the functional gap
persists for several weeks following experimentally induced injury
[58]. We also noted that control regenerating muscles exert about
the same tetanic force at one and two weeks of regeneration, which
suggests the occurrence of a prompt recovery following muscle
injury (within the first week).Thus repeated injury events, such as
those observed in dystrophic muscles, are particularly harmful
when occurring within a few days and can lead to complete loss of
muscle function.
The evidence, based on our in vitro experiments, that AVP and
TNF directly modulate myogenic differentiation, led us to
investigate the molecular mechanisms underlying this phenome-
non. We recently demonstrated that TNF-mediated caspase
activation plays a pivotal role in regulating myogenic differenti-
ation in vitro as well as muscle regeneration [6,11]. We further
confirmed the regulatory role of caspase activity in regenerating
muscle by showing that AVP blocks the TNF-induced increase in
caspase activity, thus promoting regeneration. Skeletal muscle
regeneration is an additional example of the involvement of
caspases in the regulation of embryonic stem and somatic cell
differentiation [6,59–61]. Hsp70 and PW1 are two important
modulators of caspase activity. PW1 is expressed in stem cells,
including myogenic cells, as well as in regenerating muscle fibers
[6,14]. Moreover, it recruits components of the p53-dependent
apoptotic pathway to modulate myogenic differentiation in the
presence of TNF [11]. In vivo PW1 modulates cachexia and fiber
size in concert with p53 [13]. Hsp70 plays an anti-apoptotic role
through the inhibition of the apoptosome in many cell types [17].
We discovered, by two-dimensional electrophoretic analysis and
liquid chromatography coupled with tandem mass spectrometry,
that Hsp70 binds to PW1. Given the pivotal role played by PW1 in
caspase activation in response to TNF, and the role played by
Hsp70 as a controller of caspase activation, we hypothesized that
their binding might play a role in the regulation of caspase activity
by TNF and/or AVP in muscle cells. We demonstrated that PW1
and Hsp70 are expressed and colocalize in myogenic cells in both
growth and differentiation conditions. Moreover, we showed, by
means of reciprocal immunoprecipitation experiments, that Hsp70
binds to PW1 in L6 cells. PW1-Hsp70 binding holds true in non-
muscle cells, where ectopically expressed PW1 is co-immunopre-
cipitated with endogenous Hsp70. This suggests that Hsp70
inhibits caspase activation in response to TNF by binding PW1
and blocking its ability to elicit caspase activation. Indeed, we
found that upregulation of Hsp70 expression by various means
reduces TNF-mediated caspase activation both in vitro and in vivo:
we overexpressed Hsp70 in L6 cells and found that Hsp70
overexpression reduces the number of cells with active caspases in
the presence of TNF; in vivo Hsp70 is expressed in skeletal muscle
and its expression levels inversely correlate with caspase activity in
muscles treated with TNF and/or AVP. Interestingly, Hsp70-
overexpressing transgenic mice are resistant to age-related muscle
functional deficits [18], Hsp70 attenuates skeletal muscle damage
induced by cryolesions [19] and cardiac tissue is protected by
Hsp70 from myocardial ischemic injury [62]. In addition, Hsp70
induction by heat stress or pharmacological treatment facilitates
the regeneration of injured skeletal muscle [63,64] and increases
the survival of transplanted myoblasts [65]. For all these reasons,
Hsp70 appears to be an important factor in tissue protection and
recovery following stress or damage. We found that Hsp70 protein
levels correlate with the regenerative capacity of injured muscles,
which highlights a parallelism between caspase activity repression
and induction of regeneration by Hsp70. It is noteworthy that
TNF and AVP exerted opposite effects on Hsp70 protein levels
but not on PW1 protein levels in regenerating muscles. Hsp70
Hsp70-electroporated; AVP-treated, Hsp70-electroporated; TNF+AVP-treated, Hsp70-electroporated (*=p,0.02 vs. any of the above, by Tukey HSD
test). AVP promotes regenerating fiber growth (**=p,0.02 vs MOCK CTR, by Tukey HSD test). Thus, mock electroporated muscles recapitulate the
response to treatments observed in non-electroporated muscle. Hsp70 overexpression abrogates TNF-mediated block of regenerating fiber growth, a
phenomenon which is not further enhanced by concomitant AVP treatment.
doi:10.1371/journal.pone.0005570.g008
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muscle regeneration, indicating that Hsp70 downregulation
negatively modulates regeneration. Interestingly, AVP increased
endogenous Hsp70 protein levels and enhanced regeneration in
the absence or presence of TNF. AVP and Hsp70 overexpression
(by electroporation-mediated gene delivery) appeared not to be
synergistic on the regenerating fiber size, thereby suggesting that
either treatment on its own reaches an Hsp70 expression threshold
that triggers the maximal muscle regeneration effect.
In conclusion, we show that it is possible to counteract the
negative effects of TNF on both muscle regeneration and
performance by AVP treatment in vivo. This occurs through
previously unidentified cross-talk between TNF and AVP
pathways that is based on Hsp70 protein levels (summarized in
Fig. 9). Hsp70 is an important modulator of muscle regeneration
and its overexpression counteracts the TNF-dependent inhibition
of myogenesis in vivo responsible for hampering muscle recovery
and performance. We have previously shown that TNF-mediated
muscle wasting is associated with defective muscle regeneration
[4]. TNF-mediated caspase activation is a prerequisite for muscle
regeneration inhibition [6], and Hsp70 may counteract this block
of muscle regeneration by inhibiting caspase activation in muscle
cells. The negative effects exerted by TNF on muscle regeneration
can be rescued by hormonal (AVP), pharmacological (caspase
inhibitors) or gene delivery (DPW1 [11] or Hsp70 expression)
treatments, all of which are aimed at inhibiting caspase activation.
Materials and Methods
Cell cultures
The L6 myogenic cell line [66], subclone L6-C5 (henceforth
referred to as L6), was cultured as described by Nervi et al. [24].
The day after plating, the cultures were differentiated by shifting
the medium to DMEM supplemented with 1% FBS and treated
with AVP 10
27 M (Sigma, St. Louis, MO), TNF 5 ng/ml (Roche
Molecular Biochemicals-Boehringer Mannheim), or AVP and
TNF combined. PBS was used as a control and the media were
replenished every two days. Heat shock was performed by 1 h
incubation of L6 cells at 42uC followed by 1 h at 37uC.
Animals
To induce freeze injury, a steel probe pre-cooled in dry ice was
applied to the tibialis anterior muscle belly of anesthetized adult (7–8
weeks old) female CD1 mice for 10 seconds. Mice were treated
according to the guidelines of the Institutional Animal Care and
Use Committee. The method is described in detail elsewhere [6].
To treat muscles, we injected 25 mlo f5 mg/ml TNF-a (i.e.
7.3 mmoles/muscle), 25 mlo f1 0
24 M AVP (i.e.
25610
24 mmoles/muscle), TNF and AVP combined (25 mlo f
5 mg/ml TNF-a+25 mlo f1 0
24 M AVP) or 50 ml of PBS in the
injured tibialis anterior, 2 and 4 days following injury.
DNA delivery by electroporation and transfection
To overexpress Heat Shock Protein 70, we used a construct
with cDNA for the inducible form of Hsp70 under the control of
the SV40 promoter [67], kindly provided by Dr. Marja Jaattela
(Institute of cancer biology, Copenhagen, DK). 4.5 days after
freeze injury, 22.5 mg of Hsp70 or pCDNA (MOCK) expression
vectors were co-injected in the tibialis anterior with 2.5 mgo f
SNAP-GFP, used as a transfection marker, followed by electro-
poration. Electroporation was performed by delivering six electric
pulses of 20 V each (three with the anode placed on the front of
the injured tibialis anterior, followed by three pulses with the
polarity inverted). A pair of 365 mm Genepaddle electrodes
(BTX, San Diego, CA) placed on each side of the muscle was used.
For the in vitro experiments, L6 cells were transfected by the
Lipofectamine method following the Manufacturer’s instructions.
For each 35 mm Petri dish, 6 mg of a DNA mix, containing Hsp70
(MJ3) or pCDNA (MJ2) [67] in a 5:1 ratio with Ref Fluorescent
Protein (dsRED; Clontech, Mountain View, CA) was used. For the
caspase in situ assay experiments, the DNA mix contained Hsp70
(MJ3) or pCDNA (MJ2) in a 5:1 ratio with a SNAP-GFP construct,
Figure 9. Model for the proposed mechanism underlying the differential effects exerted by TNF and AVP on skeletal muscle
regeneration and function. A) TNF enhances caspase activation in regenerating muscle through PW1 and concomitant downregulation of Hsp70
expression. The latter binds to PW1 and diminishes caspase activation in myogenic cells. The reduced extent of regeneration and the delayed fiber
growth result in poor muscle performance. B) When combined with TNF, AVP increases Hsp70 expression, thereby yielding a caspase activity level
that is comparable to that of the control. This determines an abundant formation and growth of regenerating fibers, which in turn results in a
recovered functional output of the injured muscle.
doi:10.1371/journal.pone.0005570.g009
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the constructs before the caspase assay was performed.
Immunohistochemistry
L6 cultures were fixed in 4% formaldehyde buffered solution
and permeabilized with methanol. The cells were stained with
antibodies against PW1 ( 370 polyclonal Ab, [14]) and Hsp70
(monoclonal, Stressgen, Victoria, BC). Sarcomeric myosin heavy
chain staining was performed with the clone MF20 antibody
(supernatant, Hybridoma Bank, Iowa University, IO), as described
elsewhere [28]. AlexaFluor488-conjugated anti-rabbit (Molecular
Probes, Leiden, The Netherlands) and biotin-conjugated anti-
mouse with a Cy3-conjugated streptavidin (Jackson Immunor-
esearch, West Grove, PA) were used as secondary antibodies.
Nuclei were counterstained with DAPI. Differentiated L6 cells
were identified by sarcomeric myosin heavy chain staining (clone
MF20, hybridoma supernatant, Iowa University, IO), as described
elsewhere [28].
Photomicrographs were obtained by using an Axioskop 2 plus
system equipped with an Axiocam HRc (Zeiss, Oberkochen, GE)
at standard 130061030 pixel resolution, or a Leica Leitz DMRB
microscope fitted with a Leica DFC300FX camera. Quantitative
analysis of differentiation was performed by determining the
number of nuclei in MF20 positive cells out of the total number of
nuclei in at least ten randomly chosen microscopic fields per
sample (% differentiation).
Co-immunoprecipitation and Western Blot analysis
To test for endogenous PW1-Hsp70 interaction in vivo, L6-C5
cells were grown to 70% confluence in 150 mm plates and
subjected to heat shock treatment before harvesting. The cells
were harvested and lysed in 1 ml of lysis buffer (50 mM Tris-HCl,
pH 8.0, 5 mM EDTA, 150 mM NaCl2, 0.5% NP-40, and 1 mM
PMSF). Nuclear extracts were prepared by centrifugation
following sonication. After centrifugation, equal amounts of
protein (3 mg for co-immunoprecipitation of endogenous proteins)
were immunoprecipitated, using 2 mg of the corresponding
antibody. After pre-clearing the extracts with protein A/G (Pierce,
Rockford, IL), the PW1 and the Hsp70 proteins were immuno-
precipitated using anti-PW1 or anti-Hsp70 antibodies respectively,
followed by protein A/G sepharose. The complex was washed
three times with lysis buffer and subjected to electrophoresis on a
4–12% gradient SDS-polyacrylamide gel. The protein was
transferred to a PVDF membrane, probed with anti-PW1 and
anti-Hsp70 antibody, and developed using an ECL chemilumi-
nescence kit (Pierce). 293 cells were grown to 60% confluence in
100 mm plates and transfected with pcDNA3.1, PMT HA-tagged
PW1 (exon 9), PEF HA-tagged PW1 (exon 9) or PW1 FL (full-
length) by standard calcium-phosphate transfection procedures.
Each plate contained pCMV b-galactosidase expression vectors as
an internal control and the total amount of plasmid was adjusted
with empty pcDNA3.1 expression vector. Cells were harvested
48 h after transfection and lysed in 500 ml of lysis buffer (50 mM
Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl2, 0.5% NP-40,
and 1 mM PMSF) per 100 mm plate. After sonication and pre-
clearing, the cells lysates were mixed with anti-PW1 antibody,
anti-HA antibody (C12A5 SIGMA) or anti-Hsp70 (Stressgen) for
two hours, followed by overnight precipitation with protein A/G
sepharose (Pierce). For immunoblotting, proteins were resolved in
4–12% SDS-PAGE, then transferred to PVDF membranes and
probed with antibodies to PW1 or Hsp70 (Stressgen). Tissue
extracts, obtained from muscle at 4.5 days following regeneration
[4], were immunoblotted with antibodies to Pax7, desmin (Sigma)
or tubulin (Sigma). Immunoblots were developed using horserad-
ish peroxidase-conjugated antibodies, followed by detection with
enhanced chemiluminescence.
Caspase activity assays
The CaspGLOW
TM red active caspase staining kit (Biovision,
Old Middlefield Way, CA) was used to quantify caspase activity
from muscle lysates. The injured area of the tibialis anterior was
isolated, finely minced and transferred to 1.5 ml tubes. Samples
were then incubated with a Red-VAD-FMK 1:300 dilution in PBS,
in a water bath at 37uC for 45 min. After centrifugation at 150 g,
samples were washed twice in the Manufacturer’s Wash buffer for
10 min each, and lysed in 1 ml of lysis buffer (5 mM Tris-HCl
pH=8; 10 mM EDTA; 0.5% Triton) for 30 min at 4uC. The
cytosolicfractionwasused toperformtheenzymaticassay,whilethe
nuclear pellet was used to measure DNA content, as described
previously [6,68]. Fluorometric readings were performed at a
wavelength pair of 540/570 nm excitation/emission for caspase
activity, and 365/460 nm excitation/emission for DNA content.
Samples were normalized by DNA content and expressed as the
fold increase over controls (injured, PBS-treated muscle).
Alternatively, CaspGLOW
TM was used for an in situ caspase
assay on myogenic cells. Apoptosis was induced in L6 cells by
overnight treatment with 2.5 mg/ml puromycin (Sigma, St. Louis,
MO) [69]. Alternatively, caspase activation was triggered by 5 ng/
ml TNF treatment overnight in GM. The adherent cells were
detached by digestion with trypsin and pooled with the floating
cells, and the assay was performed following the Manufacturer’s
instructions for cells in suspension.
RT-PCR
Total RNA was prepared from the tibialis anterior using Trizol
Reagent (Invitrogen, Carlsbad, CA), following the manufacturer’s
protocol. RT-PCR was performed using 2 mg of total RNA
reverse-transcribed using Moloney murine leukemia virus reverse
transcriptase (M-MLV RT; Invitrogen). PCR reactions were
carried out in a final volume of 50 ml in a buffer containing 1 mlo f
RT reaction, 200 mM dNTP, 1.5 mM MgCl2, 0.2 mM of each
primer, and 1 U of Taq-DNA polymerase (Invitrogen). The PCR
products were analyzed in 2% agarose gel. The following specific
primers were used:
Neonatal MHC: forward: 59-AACTGAGGAAGACCGCAAG-
AATG-39, reverse: AAGTAAACCCAGAGAGGCAAGTGACC-
39.
Glyceraldehyde 3-phosphate dehydrogenase transcript (used as
internal control): GAPDH: forward: 59-AACATCAAATGGGGT-
GAGGCC-39, reverse: 59-GTTGTCATGGATGACCTTGGC-39.
Functional analysis
Functional analysis was performed according to a previously
described protocol [70,71]. Briefly, the tibialis anterior was
carefully dissected, the mass measured (weight) and vertically
mounted in a temperature controlled chamber (30uC), where it
was immersed in a standard Krebs-Ringer bicarbonate buffer
solution (Sigma) and continuously gassed with a mixture of 95%
O2 and 5% CO2. One end of the muscle was linked to a fixed
clamp while the other end was connected to the lever-arm of an
ASI 300 b Dual-Mode actuator/transducer with a non-compliant
nylon wire. Muscles were electrically stimulated by means of a pair
of electrodes, and evoked forces were continuously acquired.
Muscles were initially stimulated with three 0.5 ms single pulses
and subsequently with two trains of 0.1 ms pulses performed at an
unfused frequency (120 Hz pulses for 0.4 s). To evoke tetanic force
(tetanic force), muscles were then stimulated with two trains of
0.1 ms pulses (160 Hz pulses for 0.4 s). Specific force was calculated
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muscles were subjected to a series of closer trains of pulses (0.4 s
train of 120 Hz pulses) to induce isometric fatigue (fatigue index).
During the fatigue stimulation, we measured the ability of the
muscle to resist to repeated stimulations by calculating the time
required to halve the value of its own maximum force (fatigue time).
Morphometric analysis and statistics
For the morphological evaluation of skeletal muscle, cryosec-
tions were stained with Haematoxylin and Eosin (H&E, Sigma)
using standard methods. Morphometric evaluation of the sections
was carried out as described previously [6]. Briefly, photomicro-
graphs of all the regenerating, H&E stained fibers (identified by
morphological criteria, i.e. centrally located nuclei) in any
cryosections were taken at standard (130061030 pixel) resolution
and analyzed using Scion Image software (version Beta 4.0.2,
Scion Corporation, Frederick; MD). For the evaluation of fiber
size, between 200 and 1000 cross-sectioned fibers per sample were
analyzed. Quantitative data were obtained from at least three
independent experiments in triplicate and the values are expressed
as mean6SEM.
To statistically analyze the muscle performance as a function of
the various treatments used in this study, we used Principal
Component Analysis (PCA). PCA is a procedure for analyzing
multivariate data that establishes ‘‘metric’’ differences between
groups under investigation on the basis of their characterizing
multivariate data [72]. We studied 6 treatment groups, each of
which contained numerous individual samples. Several parameters
that are indicative of muscle functional properties (maximum
force, weight of each muscle, specific force, fatigue index and
fatigue time) were considered in the PCA, as previously described
[72–74]. PCA transforms the original variables into new
uncorrelated ones that can be displayed in a bidimensional space
and that account for most of the variability observed, thus
reducing the dimensionality of the data and allowing a large
number of variables to be visualized in a two dimensional plot.
The coefficients by which the variables are multiplied to obtain the
1
st and 2
nd principal components are shown in Table 3. The
highest score coefficients indicate the variables that correlate most
closely with the two principal components. A diagram of the values
obtained from the muscles in each group was plotted in the
bidimensional space, defined by the 1
st and 2
nd principal
component functions The use of the 1
st and 2
nd principal
components allows the groups being investigated to be effectively
discriminated.
To compare the centroids denoted by the groups, a Manova
(multivariate analysis of variance) was performed on the variables.
One-way or two-way Anova were used respectively for one or two
variate analysis. Either the least squares difference (LSD) test or
the Tukey LSD test was used for the post hoc comparison between
specific groups. The significance level was set at a p,0.05, if not
otherwise specified. Statistical analyses were performed with SPSS
(statistical package for social sciences) 9.0.
Supporting Information
Figure S1 Analysis of the PW1 immunoprecipitation products
by two-dimensional electrophoretic analysis and liquid chroma-
tography coupled with tandem mass spectrometry (LC-MS/MS)
in two mammalian cell lines. Endogenous PW1 was immunopre-
cipitated from two mouse myogenic cell lines, F3 and C2C12.
Murine PW1 was immunoprecipitated following forced expression
in human HEK293 cells. Immunoprecipitation products were
analyzed by two-dimensional electrophoretic analysis and liquid
chromatography coupled with tandem mass spectrometry (LC-
MS/MS). The spots analyzed further were chosen after a
Progenesis analysis (Progenesis software was used to vectorize
the spots in gels and to identify differently expressed spots among
the samples. 43 spots were picked, digested overnight and
analyzed by LC-MS/MS). F3 was used as a negative control
because these cells do not express PW1, and spots present in F3
were consequently considered as unspecific binding. Hsp70 and
VDAC-1 appeared as potential PW1 binding partners of both
endogenous and overexpressed PW1, while HNRP and enolase
were detected only when PW1 was overexpressed.
Found at: doi:10.1371/journal.pone.0005570.s001 (0.98 MB TIF)
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